William Hoffman - Aug 5, 2021 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Signature
/s/ Angela Ahmad, attorney-in-fact for William Hoffman
Stock symbol
NARI
Transactions as of
Aug 5, 2021
Transactions value $
-$2,799,974
Form type
4
Date filed
8/6/2021, 01:13 PM
Previous filing
Jul 7, 2021
Next filing
Sep 8, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$250K -2.7K -0.35% $92.58 758K Aug 5, 2021 Direct F1, F2, F3
transaction NARI Common Stock Sale -$1.61M -17.3K -2.28% $93.08 741K Aug 5, 2021 Direct F1, F3, F4
transaction NARI Common Stock Sale -$944K -10K -1.36% $93.96 731K Aug 5, 2021 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020.
F2 This transaction was executed in multiple trades at prices ranging from $91.76 to $92.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Includes 235 shares acquired on July 30, 2021 under the Employee Stock Purchase Plan since the reporting person's last Form 4 filing.
F4 This transaction was executed in multiple trades at prices ranging from $92.77 to $93.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 This transaction was executed in multiple trades at prices ranging from $93.77 to $94.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.